Incyte
INCY
#1156
Rank
โ‚น1.722 T
Marketcap
โ‚น8,776
Share price
-0.33%
Change (1 day)
48.92%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): โ‚น531.23

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น551.94. In 2024 the company made an earnings per share (EPS) of โ‚น27.96 a decrease over its 2023 EPS that were of โ‚น240.80.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น531.231800.12%
2024โ‚น27.96-88.39%
2023โ‚น240.8073.38%
2022โ‚น138.89-64.1%
2021โ‚น386.90-408.63%
2020-โ‚น125.36-166.83%
2019โ‚น187.59300%
2018โ‚น46.90-133.33%
2017-โ‚น140.69-378.57%
2016โ‚น50.502700%
2015โ‚น1.80-106.67%
2014-โ‚น27.06-44.44%
2013-โ‚น48.7050%
2012-โ‚น32.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,175 112.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น215.54-60.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น1,850 235.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น155.12-71.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น10.82-101.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น20.74-103.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น663.77 20.26%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AVEO Oncology
AVEO
-โ‚น75.76-113.73%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น52.31-109.48%๐Ÿ‡บ๐Ÿ‡ธ USA